keyword
https://read.qxmd.com/read/38642964/should-renin-angiotensin-system-inhibitors-be-held-prior-to-major-surgery
#1
EDITORIAL
Matthieu Legrand
Many patients undergoing surgical procedures have a history of hypertension, diabetes mellitus, heart failure, or a combination. Often, these conditions involve the chronic use of a renin-angiotensin system inhibitor, including angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs). Observational studies have suggested that continuing ACEIs/ARBs before major noncardiac surgery can increase the risk of intraoperative hypotension, which might drive postoperative complications such as acute kidney injury, myocardial injury, or stroke...
May 2024: British Journal of Anaesthesia
https://read.qxmd.com/read/38640337/role-and-molecular-mechanism-of-salvia-miltiorrhiza-associated-with-chemical-compounds-in-the-treatment-of-diabetes-mellitus-and-its-complications-a-review
#2
JOURNAL ARTICLE
Jiajie Li, Jinxing Liu, Weibing Shi, Jinchen Guo
Diabetes mellitus (DM) is one of the most prevalent diseases worldwide, greatly impacting patients' quality of life. This article reviews the progress in Salvia miltiorrhiza, an ancient Chinese plant, for the treatment of DM and its associated complications. Extensive studies have been conducted on the chemical composition and pharmacological effects of S miltiorrhiza, including its anti-inflammatory and antioxidant activities. It has demonstrated potential in preventing and treating diabetes and its consequences by improving peripheral nerve function and increasing retinal thickness in diabetic individuals...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38576485/efficacy-of-traditional-chinese-medicine-versus-angiotensin-converting-enzyme-inhibitors-angiotensin-receptor-blockers-and-their-combinations-in-the-treatment-of-iga-nephropathy-a-systematic-review-and-network-meta-analysis
#3
Sijia Ma, Yuhua Jiang, Linlin Qian, Meng Wang, Shijie Xu, Guowei Wang
BACKGROUND: IgA nephropathy (IgAN), a condition posing a significant threat to public health, currently lacks a specific treatment protocol. Research has underscored the potential benefits of traditional Chinese medicine (TCM) for treating IgAN. Nevertheless, the effectiveness of various intervention strategies, such as combining TCM with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), lacks a comprehensive systematic comparison. Therefore, this study aimed to conduct a network meta-analysis to assess the clinical efficacy of ACEIs, ARBs, TCM, and their combinations in treating IgAN to offer novel insights and approaches for the clinical management of IgAN...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38570269/nano-ceo-2-activates-physical-and-chemical-defenses-of-garlic-allium-sativum-l-for-reducing-antibiotic-resistance-genes-in-plant-endosphere
#4
JOURNAL ARTICLE
Yinuo Xu, Mengna Tao, Wei Xu, Lanqing Xu, Le Yue, Xuesong Cao, Feiran Chen, Zhenyu Wang
The transmission of manure- and wastewater-borne antibiotic-resistant bacteria (ARB) to plants contributes to the proliferation of antimicrobial resistance in agriculture, necessitating effective strategies for preventing the spread of antibiotic resistance genes (ARGs) from ARB in the environment to humans. Nanomaterials are potential candidates for efficiently controlling the dissemination of ARGs. The present study investigated the abundance of ARGs in hydroponically grown garlic (Allium sativum L.) following nano-CeO2 (nCeO2 ) application...
April 2, 2024: Ecotoxicology and Environmental Safety
https://read.qxmd.com/read/38557512/comparative-efficacy-and-safety-of-amlodipine-and-losartan-potassium-in-essential-hypertension-in-a-tertiary-hospital-of-bangladesh
#5
JOURNAL ARTICLE
R N Shimu, S Majumder, F Tarannum, D P Chowdhury, A Nahar, A Afrin, M Akter, S Nahar, S Jahan, M A Hossain
Hypertension is a common disorder of major clinical, public health and economic importance. It affects men and women of all ages, and the prevalence is increasing in most countries. Maintenance of blood pressure below 140/90 mm of Hg is recommended by most of the guideline available around the world. Various classes of drugs are being used in the treatment of hypertension. Losartan potassium and amlodipine are two different antihypertensive agents belonging to two different groups used commonly around the world in treating essential hypertension...
April 2024: Mymensingh Medical Journal: MMJ
https://read.qxmd.com/read/38511239/effects-of-the-valsartan-recall-on-heart-failure-patients-a-nationwide-analysis
#6
JOURNAL ARTICLE
Joshua W Devine, Mina Tadrous, Inmaculada Hernandez, Nandita Mukhopadhyay, Scott D Rothenberger, Katherine Callaway Kim, Walid F Gellad, Katie J Suda
BACKGROUND: Valsartan is commonly used for cardiac conditions. In 2018, the Food and Drug Administration recalled generic valsartan due to the detection of impurities. Our objective was to determine if heart failure patients receiving valsartan at the recall date had a greater likelihood of unfavorable outcomes than patients using comparable antihypertensives. METHODS: We conducted a cohort study of Optum's de-identified Clinformatics® Datamart (July 2017-January 2019)...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38509517/investigating-the-use-of-finerenone-in-children-with-chronic-kidney-disease-and-proteinuria-design-of-the-fiona-and-open-label-extension-studies
#7
RANDOMIZED CONTROLLED TRIAL
Franz Schaefer, Giovanni Montini, Hee Gyung Kang, Johan Vande Walle, Joshua Zaritsky, Michiel F Schreuder, Mieczyslaw Litwin, Andrea Scalise, Helen Scott, James Potts, Pablo Iveli, Stefanie Breitenstein, Bradley A Warady
INTRODUCTION: Proteinuria is a modifiable risk factor for chronic kidney disease (CKD) progression in children. Finerenone, a selective, non-steroidal, mineralocorticoid receptor antagonist (MRA) has been approved to treat adults with CKD associated with type 2 diabetes mellitus (T2DM) following results from the phase III clinical trials FIDELIO-DKD (NCT02540993) and FIGARO-DKD (NCT02545049). In a pre-specified pooled analysis of both studies (N = 13,026), finerenone was shown to have an acceptable safety profile and was efficacious in decreasing the risk of adverse kidney and cardiovascular outcomes and of proteinuria...
March 21, 2024: Trials
https://read.qxmd.com/read/38508844/sacubitril-valsartan-in-patients-hospitalized-with-decompensated-heart%C3%A2-failure
#8
RANDOMIZED CONTROLLED TRIAL
David A Morrow, Eric J Velazquez, Akshay S Desai, Adam D DeVore, Serge Lepage, Jeong-Gun Park, Kavita Sharma, Scott D Solomon, Randall C Starling, Jonathan H Ward, Kristin M Williamson, Shelley Zieroth, Adrian F Hernandez, Robert J Mentz, Eugene Braunwald
BACKGROUND: The efficacy and safety of sacubitril/valsartan in patients hospitalized with heart failure (HF) across the spectrum of left ventricular ejection fraction (EF) has not been described. OBJECTIVES: Data from randomized trials of sacubitril/valsartan in HF patients with EF ≤40% (PIONEER-HF [Comparison of Sacubitril/Valsartan Versus Enalapril on Effect of NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode] trial) and >40% (PARAGLIDE-HF [Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF] trial) following recent worsening heart failure (WHF) were pooled to examine treatment effect across the EF spectrum...
March 26, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38496070/a-comparative-study-of-the-safety-and-efficacy-between-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-on-the-management-of-hypertension-a-systematic-review
#9
REVIEW
Tariladei S Peresuodei, Abhishek Gill, Chijioke Orji, Maiss Reghefaoui, Michell Susan Saavedra Palacios, Tuheen Sankar Nath
Renin-angiotensin-aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in the management of hypertension. High blood pressure is a vital risk factor for cardiovascular disease. This study aims to establish any significant difference in using ACEIs and ARBs in managing hypertension. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct this systematic review...
February 2024: Curēus
https://read.qxmd.com/read/38481547/effectiveness-of-chinese-herbal-medicine-compared-with-angiotensin-ii-receptor-blockers-in-patients-with-diabetic-kidney-disease-a-hospital-based-matched-cohort-study
#10
JOURNAL ARTICLE
Yuan-Ching Liao, Mei-Yao Wu, Yu-Chuen Huang, Che-Yi Chou, Hung-Rong Yen
Angiotensin II receptor blockers (ARBs) are one of the standard treatments for diabetic kidney disease (DKD). Some patients may opt for Chinese herbal medicine (CHM) of their own free will. However, there is no real-world evidence regarding the effectiveness and safety of CHM. We aimed to explore the effectiveness of CHM for DKD in comparison to ARBs. We enrolled 732 DKD patients (72 used only CHM and 661 used ARBs) from 2007 to 2016, and all patients were followed until December 2016 at China Medical University Hospital in Taiwan...
March 2024: Journal of Traditional and Complementary Medicine
https://read.qxmd.com/read/38479171/assessment-of-antibiotic-resistant-infection-risks-associated-with-reclaimed-wastewater-irrigation-in-intensive-tomato-cultivation
#11
JOURNAL ARTICLE
Samira Nahim-Granados, Hunter Quon, María Inmaculada Polo-López, Isabel Oller, Ana Agüera, Sunny Jiang
Agricultural irrigation using reclaimed urban wastewater (RWW) represents a sustainable practice to meet the ever-increasing water stress in modern societies. However, the occurrence of residual antibiotics and antibiotic resistant bacteria (ARB) in RWW is an important human health concern. This study applied for the first time a novel Simple-Death dose-response model to the field data of Escherichia coli and Pseudomonas spp. collected from three greenhouses for cultivation of tomatoes irrigated with RWW. The model estimates the risk of infection by enteropathogenic E...
March 7, 2024: Water Research
https://read.qxmd.com/read/38465175/the-safety-and-efficacy-of-the-early-use-of-sacubitril-valsartan-after-acute-myocardial-infarction-a-meta-analysis-of-randomized-controlled-trials
#12
REVIEW
Abdullah -, Majid Rashid, Cuauhtemoc Jeffrey Soto, Ghazala S Virk, Favour C Mekowulu, Sandipkumar S Chaudhari, Saima Batool, Muhammad Usama
Acute myocardial infarction (AMI) is a significant global cause of mortality, necessitating the exploration of innovative treatments against the condition. Angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs), and angiotensin receptor-neprilysin inhibitors (ARNIs) such as sacubitril/valsartan have demonstrated promise in managing acute heart failure (HF). However, despite favorable evidence from clinical trials for the use of sacubitril/valsartan in AMI, its overall efficacy remains a subject of debate...
February 2024: Curēus
https://read.qxmd.com/read/38434903/biophysical-analysis-of-potential-inhibitors-of-sars-cov-2-cell-recognition-and-their-effect-on-viral-dynamics-in-different-cell-types-a-computational-prediction-from-in-vitro-experimental-data
#13
JOURNAL ARTICLE
Lenin González-Paz, Carla Lossada, María Laura Hurtado-León, Joan Vera-Villalobos, José L Paz, Yovani Marrero-Ponce, Felix Martinez-Rios, Ysaías J Alvarado
Recent reports have suggested that the susceptibility of cells to SARS-CoV-2 infection can be influenced by various proteins that potentially act as receptors for the virus. To investigate this further, we conducted simulations of viral dynamics using different cellular systems (Vero E6, HeLa, HEK293, and CaLu3) in the presence and absence of drugs (anthelmintic, ARBs, anticoagulant, serine protease inhibitor, antimalarials, and NSAID) that have been shown to impact cellular recognition by the spike protein based on experimental data...
February 27, 2024: ACS Omega
https://read.qxmd.com/read/38418982/safety-and-efficacy-of-pyronaridine-artesunate-paediatric-granules-in-the-treatment-of-uncomplicated-malaria-in-children-insights-from-randomized-clinical-trials-and-a-real-world-study
#14
JOURNAL ARTICLE
Michael Ramharter, Abdoulaye A Djimde, Isabelle Borghini-Fuhrer, Robert Miller, Jangsik Shin, Adam Aspinall, Naomi Richardson, Martina Wibberg, Lawrence Fleckenstein, Sarah Arbe-Barnes, Stephan Duparc
BACKGROUND: Children are particularly at risk of malaria. This analysis consolidates the clinical data for pyronaridine-artesunate (PA) paediatric granules in children from three randomized clinical trials and a real-world study (CANTAM). METHODS: An integrated safety analysis of individual patient data from three randomized clinical trials included patients with microscopically-confirmed Plasmodium falciparum, body weight ≥ 5 kg to < 20 kg, who received at least one dose of study drug (paediatric safety population)...
February 28, 2024: Malaria Journal
https://read.qxmd.com/read/38394516/the-effects-of-salvia-miltiorrhiza-and-ligustrazine-injection-combined-with-acei-arb-on-diabetic-kidney-disease-a-systematic-review-and-meta-analysis
#15
JOURNAL ARTICLE
Zixuan Zhang, Lei Luo, Xueling Li, Yifei Zhong
BACKGROUND: In China, Salvia miltiorrhiza and ligustrazine (SML) injection are widely used as adjunctive therapy for patients with diabetic kidney disease (DKD). However, different studies have reported conflicting results. Therefore, a systematic review and meta-analysis are necessary to assess the efficacy and safety of SML injection for the treatment of DKD. METHODS: We searched 6 electronic literature databases comparing randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB), SML injection in combination with ACEIs/ARBs that were conducted from inception until September 5, 2023...
February 23, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38365637/comparative-estimation-of-the-effects-of-antihypertensive-medications-on-schizophrenia-occurrence-a-multinational-observational-cohort-study
#16
JOURNAL ARTICLE
Dong Yun Lee, Chungsoo Kim, Jiwoo Kim, Jeongwon Yun, Yujin Lee, Celine Sze Ling Chui, Sang Joon Son, Rae Woong Park, Seng Chan You
BACKGROUND: The association between antihypertensive medication and schizophrenia has received increasing attention; however, evidence of the impact of antihypertensive medication on subsequent schizophrenia based on large-scale observational studies is limited. We aimed to compare the schizophrenia risk in large claims-based US and Korea cohort of patients with hypertension using angiotensin-converting enzyme (ACE) inhibitors versus those using angiotensin receptor blockers (ARBs) or thiazide diuretics...
February 16, 2024: BMC Psychiatry
https://read.qxmd.com/read/38362830/sparsentan-the-first-and-only-non-immunosuppressive-therapy-for-the-reduction-of-proteinuria-in-iga-nephropathy
#17
REVIEW
Howard Trachtman, Radko Komers, Jula Inrig
INTRODUCTION: IgA nephropathy is one of the most common forms of glomerular disease. Patients with persistent proteinuria are at increased risk of progression to kidney failure. There is a significant need for safe and effective therapies to lower proteinuria in these patients. Sparsentan is a non-immunosuppressive agent that acts as a dual angiotensin and endothelin receptor antagonist. It lowers proteinuria in experimental models of glomerular disease and in affected patients. AREAS COVERED: This review covers the immunological and non-immunological actions of sparsentan in glomerular disease...
February 16, 2024: Expert Review of Clinical Immunology
https://read.qxmd.com/read/38350635/from-hypertension-to-beyond-unraveling-the-diverse-mechanisms-of-olmesartan-in-disease-modulation
#18
JOURNAL ARTICLE
Laiba Rind, Tarique Mahmood, Mohammed Haris Siddiqui, Farogh Ahsan, Arshiya Shamim, Aamir Anwar, Rajnish Kumar Yadav
Olmesartan, originally known for its antihypertensive properties, exhibits promising potential in addressing inflammation-mediated diseases. As an angiotensin II receptor blocker (ARB), Olmesartan influences pivotal pathways, including reactive oxygen species, cytokines, NF-κB, TNF-α, and MAPK. This suggests a viable opportunity for repurposing the drug in conditions such as ulcerative colitis, neuropathy, nephropathy, and cancer, as supported by multiple preclinical studies. Ongoing clinical trials, particularly in cardiomyopathy and nephropathy, suggest a broader therapeutic scope for Olmesartan...
March 2024: Drug Research
https://read.qxmd.com/read/38332411/management-of-hypertension-in-the-asia-pacific-region-a-structured-review
#19
REVIEW
Abdul R A Rahman, Jose Donato A Magno, Jun Cai, Myint Han, Hae-Young Lee, Tiny Nair, Om Narayan, Jiampo Panyapat, Huynh Van Minh, Rohit Khurana
This article reviews available evidence regarding hypertension management in the Asia-Pacific region, focussing on five research questions that deal with specific aspects: blood pressure (BP) control, guideline recommendations, role of renin-angiotensin-aldosterone system (RAAS) inhibitors in clinical practice, pharmacological management and real-world adherence to guideline recommendations. A PubMed search identified 2537 articles, of which 94 were considered relevant. Compared with Europeans, Asians have higher systolic/diastolic/mean arterial BP, with a stronger association between BP and stroke...
February 8, 2024: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/38323189/short-term-prognosis-of-polypharmacy-in-elderly-patients-treated-in-emergency-departments-results-from-the-eden-project
#20
JOURNAL ARTICLE
Jesus Ruiz Ramos, Aitor Alquézar-Arbé, Ana Juanes Borrego, Guillermo Burillo Putze, Sira Aguiló, Javier Jacob, Cesáreo Fernández, Pere Llorens, Francisco de Borja Quero Espinosa, Susana Gordo Remartinez, Rocio Hernando González, Miguel Moreno Martín, Sara Sánchez Aroca, Alicia Sara Knabe, Rebeca González González, Marina Carrión Fernández, Alberto Artieda Larrañaga, Maria Adroher Muñoz, Jeong-Uh Hong Cho, María Teresa Escolar Martínez Berganza, Sara Gayoso Martín, Goretti Sánchez Sindín, Martina Silva Penas, Bárbara Gómez Y Gómez, Roser Arenos Sambro, Juan González Del Castillo, Òscar Miró
BACKGROUND: Polypharmacy is a growing phenomenon among elderly individuals. However, there is little information about the frequency of polypharmacy among the elderly population treated in emergency departments (EDs) and its prognostic effect. This study aims to determine the prevalence and short-term prognostic effect of polypharmacy in elderly patients treated in EDs. METHODS: A retrospective analysis of the Emergency Department Elderly in Needs (EDEN) project's cohort was performed...
2024: Therapeutic Advances in Drug Safety
keyword
keyword
82037
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.